Naheed A Lakhani1, Mona Saraiya2, Trevor D Thompson3, Sallyann Coleman King4, Gery P Guy5. 1. Emory University School of Medicine, USA. Electronic address: Naheeda786@gmail.com. 2. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, USA. Electronic address: yzs2@cdc.gov. 3. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, USA. Electronic address: tkt2@cdc.gov. 4. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, USA. Electronic address: fjq9@cdc.gov. 5. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, USA. Electronic address: irm2@cdc.gov.
Abstract
OBJECTIVE: Melanoma incidence and mortality are increasing among United States adults. At present, routine skin cancer screening via total body skin examinations (TBSEs) by a physician is not recommended by the United States Preventive Services Task Force (USPSTF); while organizations such as the American Cancer Society recommend screening. Currently, there are limited data on the prevalence, correlates, and trends of TBSE among United States adults. METHODS: We analyzed data by race/ethnicity, age, and skin cancer risk level, among other characteristics from three different National Health Interview Survey (NHIS) cancer control supplements conducted every five years since 2000 in random United States households. High-risk status and middle-risk status were defined based on the USPSTF criteria (age, race, sunburn, and family history). RESULTS: Prevalence of having at least one TBSE increased from 14.5 in 2000 to 16.5 in 2005 to 19.8 in 2010 (P<0.0001). In 2010, screening rates were higher among the elderly, the fair-skinned, those reporting sunburn(s), and individuals with a family history of skin cancer. Approximately 104.7million (51.1%) U.S. adults are at high-risk for developing melanoma, of which 24.0% had at least one TBSE. CONCLUSIONS: TBSE rates have been increasing since 2000 both overall and among higher-risk groups. Data on screening trends could help tailor future prevention strategies. Published by Elsevier Inc.
OBJECTIVE:Melanoma incidence and mortality are increasing among United States adults. At present, routine skin cancer screening via total body skin examinations (TBSEs) by a physician is not recommended by the United States Preventive Services Task Force (USPSTF); while organizations such as the American Cancer Society recommend screening. Currently, there are limited data on the prevalence, correlates, and trends of TBSE among United States adults. METHODS: We analyzed data by race/ethnicity, age, and skin cancer risk level, among other characteristics from three different National Health Interview Survey (NHIS) cancer control supplements conducted every five years since 2000 in random United States households. High-risk status and middle-risk status were defined based on the USPSTF criteria (age, race, sunburn, and family history). RESULTS: Prevalence of having at least one TBSE increased from 14.5 in 2000 to 16.5 in 2005 to 19.8 in 2010 (P<0.0001). In 2010, screening rates were higher among the elderly, the fair-skinned, those reporting sunburn(s), and individuals with a family history of skin cancer. Approximately 104.7million (51.1%) U.S. adults are at high-risk for developing melanoma, of which 24.0% had at least one TBSE. CONCLUSIONS:TBSE rates have been increasing since 2000 both overall and among higher-risk groups. Data on screening trends could help tailor future prevention strategies. Published by Elsevier Inc.
Entities:
Keywords:
Cancer screening; Early diagnosis of cancer; Melanoma; Skin cancer
Authors: Howard W Rogers; Martin A Weinstock; Ashlynne R Harris; Michael R Hinckley; Steven R Feldman; Alan B Fleischer; Brett M Coldiron Journal: Arch Dermatol Date: 2010-03
Authors: H K Koh; L A Norton; A C Geller; T Sun; D S Rigel; D R Miller; R G Sikes; K Vigeland; E U Bachenberg; P A Menon; S F Billon; G Goldberg; D A Scarborough; W M Ramsdell; V A Muscarella; R A Lew Journal: J Am Acad Dermatol Date: 1996-06 Impact factor: 11.527
Authors: Kimberly A Miller; Bryan M Langholz; John Zadnick; Ann S Hamilton; Wendy Cozen; Thomas M Mack; Myles G Cockburn Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-20 Impact factor: 4.254
Authors: Richard A Shellenberger; Karine Tawagi; Sweta Kakaraparthi; Jeremy Albright; Mohammed Nabhan; Alan C Geller Journal: J Gen Intern Med Date: 2018-11 Impact factor: 5.128
Authors: Bridget Grahmann Parsons; Lisa H Gren; Sara E Simonsen; Garrett Harding; Douglas Grossman; Yelena P Wu Journal: J Community Health Date: 2018-04
Authors: Mary K Tripp; Meg Watson; Sophie J Balk; Susan M Swetter; Jeffrey E Gershenwald Journal: CA Cancer J Clin Date: 2016-05-27 Impact factor: 508.702
Authors: Kelly C Nelson; Elizabeth V Seiverling; Nadeen Gonna; Elizabeth Berry; Elizabeth Stoos; Chloe N Dorsey; Sarah Sepulveda; Gerardo Vazquez; Hung Q Doan; Lauren E Haydu Journal: J Cancer Educ Date: 2022-01-10 Impact factor: 2.037